• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个由经活检确诊的特发性炎症性肌病患者组成的大队列中,恶性肿瘤的发病率及其相关性。

The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis.

机构信息

Department of Rheumatology, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia.

出版信息

Rheumatol Int. 2013 Apr;33(4):965-71. doi: 10.1007/s00296-012-2489-y. Epub 2012 Jul 26.

DOI:10.1007/s00296-012-2489-y
PMID:22833242
Abstract

The South Australian (SA) myositis database has registered all patients with biopsy-proven inflammatory myositis in SA from 1980 to 2009. We determined the incidence and associations of malignancy in myositis by linking this database with the SA cancer registry. Standardized incidence ratios (SIR) for malignancy were determined using the total SA population over the same time period, stratified by age and gender. The SIR for cancer in the myositis population (n = 373) was 1.39, p = 0.047. There was a trend towards an increased SIR in dermatomyositis but no increased risk of malignancy in polymyositis or inclusion body myositis. Malignancies of the lung and prostate were the commonest and 28 % of malignancies occurred within one year of IIM diagnosis. The odds of developing cancer were significantly raised in the presence of a shawl sign, male gender, and in patients with overlap syndrome or rheumatoid arthritis whilst myalgia was a significant protective factor. HLA-A28 allele was overrepresented in patients with malignancy (11 vs 2 %, p = 0.006). Patients in SA with myositis are at modestly increased risk for malignancy. We report clinical and genetic risk factors allowing the identification of patients at greatest risk for malignancy.

摘要

南澳大利亚(SA)肌炎数据库自 1980 年至 2009 年登记了所有经活检证实的炎症性肌炎患者。我们通过将该数据库与南澳大利亚癌症登记处相联系,确定了肌炎中恶性肿瘤的发病率和关联。使用同一时期的总南澳大利亚人口,按年龄和性别分层,确定恶性肿瘤的标准化发病比(SIR)。肌炎人群(n = 373)的癌症 SIR 为 1.39,p = 0.047。皮肌炎的 SIR 呈上升趋势,但多发性肌炎或包涵体肌炎无恶性肿瘤风险增加。肺癌和前列腺癌是最常见的恶性肿瘤,28%的恶性肿瘤发生在 IIM 诊断后一年内。披肩征、男性、重叠综合征或类风湿关节炎患者的癌症发病几率显著升高,而肌痛是显著的保护因素。恶性肿瘤患者 HLA-A28 等位基因过度表达(11 对 2%,p = 0.006)。南澳大利亚的肌炎患者恶性肿瘤发病风险适度增加。我们报告了临床和遗传风险因素,这些因素可以识别恶性肿瘤风险最大的患者。

相似文献

1
The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis.在一个由经活检确诊的特发性炎症性肌病患者组成的大队列中,恶性肿瘤的发病率及其相关性。
Rheumatol Int. 2013 Apr;33(4):965-71. doi: 10.1007/s00296-012-2489-y. Epub 2012 Jul 26.
2
Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases.南澳大利亚特发性炎性肌病的发病率和流行率:组织学证实病例的 30 年流行病学研究。
Int J Rheum Dis. 2013 Jun;16(3):331-8. doi: 10.1111/j.1756-185X.2011.01669.x. Epub 2011 Oct 13.
3
Increased risk of malignancy in patients aged over 50 with idiopathic inflammatory myositis compared to patients with osteoarthritis of the knee.与膝骨关节炎患者相比,50岁以上特发性炎性肌病患者发生恶性肿瘤的风险增加。
Mod Rheumatol. 2020 Sep;30(5):870-877. doi: 10.1080/14397595.2019.1660041. Epub 2019 Sep 18.
4
Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.特发性炎性肌病与高血压和糖尿病的发病率高有关。
Int J Rheum Dis. 2010 May;13(2):132-7. doi: 10.1111/j.1756-185X.2010.01470.x.
5
Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population.他汀类药物暴露与澳大利亚人群中经组织学确诊的特发性炎性肌病的关联
JAMA Intern Med. 2018 Sep 1;178(9):1224-1229. doi: 10.1001/jamainternmed.2018.2859.
6
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.一个未经选择的完整挪威特发性炎性肌病队列中的生存率和癌症风险
Semin Arthritis Rheum. 2015 Dec;45(3):301-8. doi: 10.1016/j.semarthrit.2015.06.005. Epub 2015 Jun 17.
7
Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis.在一组经活检确诊的炎症性肌病患者中,死亡率及其主要原因。
Intern Med J. 2012 Feb;42(2):191-8. doi: 10.1111/j.1445-5994.2010.02406.x.
8
Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies.特发性炎性肌病中其他结缔组织病的患病率。
Rheumatol Int. 2019 Oct;39(10):1777-1781. doi: 10.1007/s00296-019-04411-8. Epub 2019 Aug 5.
9
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.台湾地区皮肌炎和多发性肌炎的癌症风险:一项全国性队列研究。
Arthritis Res Ther. 2010;12(2):R70. doi: 10.1186/ar2987. Epub 2010 Apr 16.
10
Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.经活检证实的炎性肌病中恶性疾病的发病率。一项基于人群的队列研究。
Ann Intern Med. 2001 Jun 19;134(12):1087-95. doi: 10.7326/0003-4819-134-12-200106190-00008.

引用本文的文献

1
Malignancy in Idiopathic Inflammatory Myopathies: Recent Insights.特发性炎性肌病中的恶性肿瘤:最新见解
Clin Rev Allergy Immunol. 2025 Aug 18;68(1):83. doi: 10.1007/s12016-025-09080-z.
2
Causality Assessment Between Idiopathic Inflammatory Myopathies and Lung Cancer: A Bidirectional 2-Sample Mendelian Randomization.特发性炎性肌病与肺癌之间因果关系的双向 2 样本 Mendelian 随机化研究。
J Clin Rheumatol. 2024 Jun 1;30(4):138-144. doi: 10.1097/RHU.0000000000002075.
3
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

本文引用的文献

1
Pathophysiology of inflammatory and autoimmune myopathies.炎症性和自身免疫性肌病的病理生理学
Presse Med. 2011 Apr;40(4 Pt 2):e237-47. doi: 10.1016/j.lpm.2011.01.005. Epub 2011 Mar 15.
2
A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.在经活检证实的特发性炎性肌病中,DR4、自身抗体和滑膜炎三者相互作用。
Rheumatol Int. 2012 Mar;32(3):611-9. doi: 10.1007/s00296-010-1637-5. Epub 2010 Dec 2.
3
Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis.
特发性炎性肌病相关癌症筛查国际指南:国际肌炎评估和临床研究组(IMACS)倡议。
Nat Rev Rheumatol. 2023 Dec;19(12):805-817. doi: 10.1038/s41584-023-01045-w. Epub 2023 Nov 9.
4
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
5
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study.皮肌炎合并间质性肺疾病的临床特征:一项回顾性病例对照研究
Rheumatol Ther. 2023 Jun;10(3):635-648. doi: 10.1007/s40744-023-00540-6. Epub 2023 Feb 18.
6
Inclusion Body Myositis and Neoplasia: A Narrative Review.包涵体肌炎与肿瘤:一篇叙述性综述。
Int J Mol Sci. 2022 Jul 1;23(13):7358. doi: 10.3390/ijms23137358.
7
Incidence of systemic autoimmune myopathies and their risk of cancer in Leeds, UK: an 11-year epidemiological study.英国利兹市系统性自身免疫性肌病的发病率及其患癌风险:一项为期11年的流行病学研究。
Rheumatol Adv Pract. 2022 Mar 28;6(1):rkac023. doi: 10.1093/rap/rkac023. eCollection 2022.
8
Update on Malignancy in Myositis-Well-Established Association with Unmet Needs.特发性炎症性肌病相关恶性肿瘤:既有明确关联,亦有未满足需求。
Biomolecules. 2022 Jan 11;12(1):111. doi: 10.3390/biom12010111.
9
Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort.自身抗体针对四个半 LIM 结构域蛋白 1(FHL1)在炎性肌病中的研究:来自澳大利亚单中心队列的研究结果。
Rheumatology (Oxford). 2022 Oct 6;61(10):4145-4154. doi: 10.1093/rheumatology/keac003.
10
Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.重新评估台湾地区皮肌炎和多发性肌炎患者恶性肿瘤的发病率、类型和危险因素。
Sci Rep. 2021 Feb 25;11(1):4545. doi: 10.1038/s41598-021-83729-5.
在一组经活检确诊的炎症性肌病患者中,死亡率及其主要原因。
Intern Med J. 2012 Feb;42(2):191-8. doi: 10.1111/j.1445-5994.2010.02406.x.
4
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.台湾地区皮肌炎和多发性肌炎的癌症风险:一项全国性队列研究。
Arthritis Res Ther. 2010;12(2):R70. doi: 10.1186/ar2987. Epub 2010 Apr 16.
5
Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy.85例特发性炎性肌病患者中的癌症相关性肌炎及抗p155自身抗体
Medicine (Baltimore). 2010 Jan;89(1):47-52. doi: 10.1097/MD.0b013e3181ca14ff.
6
Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA.在美国新英格兰北部,恶性肿瘤与皮肌炎相关,但与多发性肌炎无关。
J Rheumatol. 2009 Dec;36(12):2704-10. doi: 10.3899/jrheum.090549. Epub 2009 Nov 16.
7
Paraneoplastic myopathy.副肿瘤性肌病。
Curr Opin Rheumatol. 2009 Nov;21(6):594-8. doi: 10.1097/BOR.0b013e3283317fa5.
8
Dermatomyositis and malignancy: a retrospective study of 115 cases.皮肌炎与恶性肿瘤:115例回顾性研究
Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):77-80.
9
Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis.新发现的自身抗体:与特发性炎性肌病亚型及发病机制的关系
Curr Opin Rheumatol. 2008 Nov;20(6):675-80. doi: 10.1097/BOR.0b013e328313bff4.
10
Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.皮肌炎和多肌炎与恶性肿瘤的相关性:一项21年的回顾性研究。
J Rheumatol. 2008 Mar;35(3):438-44. Epub 2008 Jan 15.